Harmonicare Medical : DECISION OF THE LISTING REVIEW COMMITTEE AND CANCELLATION OF LISTING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1509)

DECISION OF THE LISTING REVIEW COMMITTEE

AND

CANCELLATION OF LISTING

This announcement is made by the board (the "Board") of directors of Harmonicare Medical Holdings Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the inside information provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Reference is made to (i) the Stock Exchange's notice of trading halt and the announcement of the

Company dated 1 April 2019; and (ii) the announcements of the Company dated 1 April 2019, 12

June 2019, 28 June 2019, 3 July 2019, 31 July 2019, 29 September 2019, 31 October 2019, 24

December 2019, 26 March 2020, 25 March 2020, 31 March 2020, 30 June 2020, 17 July 2020, 30 September 2020, 4 December 2020, 4 January 2021 and 10 January 2021, in relation to, among others, the update on suspension of trading of the Shares and resumption guidance (collectively, the "Prior Announcements"). Capitalised terms used but not otherwise defined herein shall have the same meanings as those used in the Prior Announcements.

DECISION OF THE LISTING REVIEW COMMITTEE

The review hearing of the Listing Review Committee ("Listing Review Committee") of the Stock Exchange was heard on 23 February 2021 for a review of the Delisting Decision. On 12 March 2021, the Listing Review Committee notified the Company that the Listing Review Committee decided to uphold the Delisting Decision.

CANCELLATION OF LISTING

On 15 March 2021, the Stock Exchange issued a letter advising the Company that the cancellation of listing of the Company's shares (the "Shares") from the Stock Exchange will be effective from 9:00 am on 25 March 2021 (the "Last Listing Date").

CONSEQUENCES OF THE SHAREHOLDERS

All shareholders and investors of the Company should note that after the Last Listing Date, whilst the share certificates of the Shares will remain valid, the Shares will not be listed on, and will not be tradeable on the Stock Exchange. Thereafter, the Company will no longer be subject to the Listing Rules of the Stock Exchange.

The Shareholders of the Company who have any queries about the implications of the cancellation of listing of the Shares are advised to obtain appropriate professional advice.

By Order of the Board

Harmonicare Medical Holdings Limited

LIN Yuming

Chairman, Executive Director and President

Hong Kong, 23 March 2021

As at the date of this announcement, the executive Directors are Mr. Lin Yuming, Mr. Yang Guo and Mr. Wei Rongda and Mr. Chen Longzhen; the non-executive Directors are Mr. Qiu Jianwei and Mr. Xu Jun; and the independent non-executive Directors are Ms. Hsu Wai Man Helen, Mr. Zhang Jide and Mr. Lin Jinting.